Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Invasive infections caused by Streptococcus pneumoniae in a tertiary-level children's hospital before the introduction of the conjugate vaccine: clinical characteristics and serotypes involved.

Pérez GM, Parra A, Casimir L, Mastroianni A, Reijtman V, Lopardo H, Bologna R.

Arch Argent Pediatr. 2013 Jun;111(3):202-5. doi: 10.1590/S0325-00752013000300005. English, Spanish.

PMID:
23732345
[PubMed - in process]
Free Article
2.

The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.

Ampofo K, Pavia AT, Chris S, Hersh AL, Bender JM, Blaschke AJ, Weng HY, Korgenski KE, Daly J, Mason EO, Byington CL.

Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72.

PMID:
22330164
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Ten-year review of invasive pneumococcal diseases in children and adults from Uruguay: clinical spectrum, serotypes, and antimicrobial resistance.

Hortal M, Camou T, Palacio R, Dibarboure H, García A.

Int J Infect Dis. 2000;4(2):91-5.

PMID:
10737845
[PubMed - indexed for MEDLINE]
Free Article
5.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

PMID:
22954038
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Pneumococcal conjugate vaccine for young children.

Selman S, Hayes D, Perin LA, Hayes WS.

Manag Care. 2000 Sep;9(9):49-52, 54, 56-7 passim. Review.

PMID:
11116663
[PubMed - indexed for MEDLINE]
Free Article
7.

Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar.

Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Del Castillo F, Hernández-Sampelayo T, Otheo E, Balboa F, Ríos E, Méndez C; Heracles Study Group.

Clin Vaccine Immunol. 2011 Jan;18(1):89-94. doi: 10.1128/CVI.00317-10. Epub 2010 Nov 3.

PMID:
21047996
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

Pediatr Infect Dis J. 2007 Sep;26(9):771-7.

PMID:
17721369
[PubMed - indexed for MEDLINE]
9.

Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.

Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ.

Pediatrics. 2004 Mar;113(3 Pt 1):443-9.

PMID:
14993532
[PubMed - indexed for MEDLINE]
10.

Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine.

Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, Hadler J, Cieslak PR, Whitney CG; Active Bacterial Core Surveillance Team.

JAMA. 2005 Oct 26;294(16):2043-51.

PMID:
16249418
[PubMed - indexed for MEDLINE]
11.

Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.

Mokaddas E, Albert MJ.

Vaccine. 2012 Dec 31;30 Suppl 6:G37-40. doi: 10.1016/j.vaccine.2012.10.061.

PMID:
23228356
[PubMed - indexed for MEDLINE]
12.

Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.

Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO Jr.

Pediatrics. 2010 Mar;125(3):429-36. doi: 10.1542/peds.2008-1702. Epub 2010 Feb 22.

PMID:
20176669
[PubMed - indexed for MEDLINE]
Free Article
13.

[Invasive pneumococcal disease in the Czech Republic in 2000-2006].

Motlová J, Benes C, Kríová P.

Epidemiol Mikrobiol Imunol. 2008 Feb;57(1):14-21. Czech.

PMID:
18318394
[PubMed - indexed for MEDLINE]
14.

The impact of HIV on Streptococcus pneumoniae bacteraemia in a South African population.

Jones N, Huebner R, Khoosal M, Crewe-Brown H, Klugman K.

AIDS. 1998 Nov 12;12(16):2177-84.

PMID:
9833859
[PubMed - indexed for MEDLINE]
15.

Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.

Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP.

Pediatr Infect Dis J. 2013 Feb;32(2):e45-53. doi: 10.1097/INF.0b013e3182788fdd.

PMID:
23080290
[PubMed - indexed for MEDLINE]
16.

Pneumococcal meningitis: A 12 year experience in a children's hospital prior to the universal immunization with a conjugate vaccine.

Berberian G, Pérez MG, Epelbaum C, Ceinos MD, Lopardo H, Rosanova MT.

Arch Argent Pediatr. 2014 Aug;112(4):332-336. English, Spanish.

PMID:
24955903
[PubMed - as supplied by publisher]
Free Article
17.

Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine.

Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F.

Pediatr Infect Dis J. 2001 Dec;20(12):1105-7.

PMID:
11740313
[PubMed - indexed for MEDLINE]
18.

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.

Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA; Gambian Pneumococcal Vaccine Trial Group.

Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46. Erratum in: Lancet. 2005 Jul 2-8;366(9479):28.

PMID:
15794968
[PubMed - indexed for MEDLINE]
19.

Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.

Watson M, Bayley K, Bell JM, Gilbert GL, Hogg G, Keil AD, Krause V, Murphy D, Roche P, Smith HV, Stewart MG, Stylianopoulos J, Turnidge J.

Commun Dis Intell Q Rep. 2003;27(4):478-87.

PMID:
15508501
[PubMed - indexed for MEDLINE]
20.

Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.

Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G; Lebanese Inter-Hospital Pneumococcal Surveillance Program.

Vaccine. 2012 Dec 31;30 Suppl 6:G11-7. doi: 10.1016/j.vaccine.2012.07.020.

PMID:
23228352
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk